The Canadian Cancer Society offers financial and emotional support along with important information about your cancer journey ...
SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link ...
Amgen will continue to advance half of the combo, PRMT5 inhibitor AMG 193, for which it is running a mid-stage trial in ...
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback